TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
VCRE

Vicore Pharma Holding AB

Healthcare · Biotechnology

9.50$ -0.7% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Income Statement

Vicore Pharma Holding AB (VCRE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 3.8 million SEK. Tick rows to compare them in a chart.

All figures in millions of SEK.

Tick rows to compare them in a chart (up to 4)

Income Statement VCRE
Line item 2022 2023 2024 2025
0.0 0.0 109 3.8
0.0 0.0 109 3.8
250 276 249 390
38 45 50 68
287 321 300 458
-287 -321 -190 -454
0.0 0.0 0.0 0.1
-289 -311 -169 -477
-288 -311 -169 -477

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?